CA2007507A1 - Sphingosine et n-methyl-sphingosine inhibiteurs de la croissance des cellules - Google Patents

Sphingosine et n-methyl-sphingosine inhibiteurs de la croissance des cellules

Info

Publication number
CA2007507A1
CA2007507A1 CA2007507A CA2007507A CA2007507A1 CA 2007507 A1 CA2007507 A1 CA 2007507A1 CA 2007507 A CA2007507 A CA 2007507A CA 2007507 A CA2007507 A CA 2007507A CA 2007507 A1 CA2007507 A1 CA 2007507A1
Authority
CA
Canada
Prior art keywords
sphingosine
methyl
pharmaceutically acceptable
prepared
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2007507A
Other languages
English (en)
Other versions
CA2007507C (fr
Inventor
Yasuyuki Igarashi
Tatsushi Toyokuni
Sen-Itiroh Hakomori
Efraim Racker
Shuji Fujita
Mamoru Sugimoto
Masayoshi Ito
Yoshiyasu Shitori
Tomoya Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mect Corp
Cornell Research Foundation Inc
Biomembrane Institute
Original Assignee
Yasuyuki Igarashi
Tatsushi Toyokuni
Sen-Itiroh Hakomori
Efraim Racker
Shuji Fujita
Mamoru Sugimoto
Masayoshi Ito
Yoshiyasu Shitori
Tomoya Ogawa
The Biomembrane Institute
Mect Corporation
Cornell Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yasuyuki Igarashi, Tatsushi Toyokuni, Sen-Itiroh Hakomori, Efraim Racker, Shuji Fujita, Mamoru Sugimoto, Masayoshi Ito, Yoshiyasu Shitori, Tomoya Ogawa, The Biomembrane Institute, Mect Corporation, Cornell Research Foundation, Inc. filed Critical Yasuyuki Igarashi
Publication of CA2007507A1 publication Critical patent/CA2007507A1/fr
Application granted granted Critical
Publication of CA2007507C publication Critical patent/CA2007507C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002007507A 1989-02-03 1990-01-10 Sphingosine et n-methyl-sphingosine inhibiteurs de la croissance des cellules Expired - Fee Related CA2007507C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30637889A 1989-02-03 1989-02-03
US306,378 1989-02-03
US39013589A 1989-08-07 1989-08-07
US390,135 1989-08-07

Publications (2)

Publication Number Publication Date
CA2007507A1 true CA2007507A1 (fr) 1990-08-03
CA2007507C CA2007507C (fr) 1998-05-19

Family

ID=26975128

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002007507A Expired - Fee Related CA2007507C (fr) 1989-02-03 1990-01-10 Sphingosine et n-methyl-sphingosine inhibiteurs de la croissance des cellules

Country Status (6)

Country Link
EP (1) EP0381514B1 (fr)
JP (1) JP2976055B2 (fr)
AT (1) ATE122560T1 (fr)
CA (1) CA2007507C (fr)
DE (1) DE69019388T2 (fr)
DK (1) DK0381514T3 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583160A (en) * 1989-02-03 1996-12-10 The Biomembrane Institute Methylsphingosine used to treat apoptosis
US5151360A (en) * 1990-12-31 1992-09-29 Biomembrane Institute Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation
US5260288A (en) * 1992-04-03 1993-11-09 The Biomembrane Institute Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives
IL121320A (en) 1997-02-23 2000-12-06 Ibr Ltd Extracts from cells or tissue of organisms which are capable of entering dormancy for inhibition of proliferation of target cells or tissue
US6107520A (en) * 1997-04-15 2000-08-22 The Board Of Trustees Of The University Of Illinois Spisulosine compounds
US6800661B1 (en) 1997-04-15 2004-10-05 Board Of Trustees Of The University Of Illinois Spisulosine compounds
USRE38793E1 (en) 1997-04-15 2005-09-06 Rinehart Kenneth L Spisulosine compounds
AUPO900297A0 (en) * 1997-09-08 1997-10-02 Medvet Science Pty. Ltd. A method of modulating cellular activity
US6649362B2 (en) 1997-09-08 2003-11-18 Medvet Science Pty. Ltd. Screening method for an agent having an effect on a sphingosine kinase signaling pathway
JP2003523338A (ja) 2000-02-16 2003-08-05 ファルマ・マール・ソシエダード・アノニマ 抗腫瘍活性を有するオキシ−及びアミノ−置換テトラヒドロフリル誘導体
EP1195604A1 (fr) * 2000-09-29 2002-04-10 Warner-Lambert Company Procedés et compositions pour la sondage de modulateurs de lipide kinases
WO2002060405A1 (fr) * 2001-01-29 2002-08-08 Cosmoferm B.V. Composition dermatologique veterinaire contenant une base sphingoide et/ou un derive de base sphingoide
KR100457113B1 (ko) * 2001-12-27 2004-11-16 한국원자력연구소 세라마이드류 또는 그 유도체와 다이메틸스핑고신을 유효성분으로 포함하는 방사선민감도 증진제
KR100459484B1 (ko) * 2002-05-20 2004-12-03 한국원자력연구소 엔-아세틸 파이토스핑고신과 다이메틸 파이토스핑고신을유효 성분으로 포함하는 방사선 치료 민감제 조성물
EP1426053A1 (fr) * 2002-12-03 2004-06-09 Fresenius Kabi Deutschland GmbH Utilisation de lipides amphiphiles pour l'inhibition de métastases
ATE539741T1 (de) 2004-11-30 2012-01-15 Tno Sphingolipide bei der behandlung und prävention von hepatischer steatose
CN102892748A (zh) * 2009-11-12 2013-01-23 德克萨斯理工大学 用于治疗过度增生性疾病的组合物和方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases

Also Published As

Publication number Publication date
DE69019388D1 (de) 1995-06-22
DK0381514T3 (da) 1995-09-04
EP0381514A2 (fr) 1990-08-08
JPH03157336A (ja) 1991-07-05
ATE122560T1 (de) 1995-06-15
DE69019388T2 (de) 1996-01-04
EP0381514A3 (fr) 1991-07-17
JP2976055B2 (ja) 1999-11-10
EP0381514B1 (fr) 1995-05-17
CA2007507C (fr) 1998-05-19

Similar Documents

Publication Publication Date Title
CA2007507A1 (fr) Sphingosine et n-methyl-sphingosine inhibiteurs de la croissance des cellules
CA2257121A1 (fr) Methodes et compositions pour le traitement de l'incontinence urinaire utilisant (s)-oxybutynine
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
CA2296036A1 (fr) Derives de dolastatine 15
CA2293706A1 (fr) Nouveaux composes d'uree n-substitues inhibiteurs de la farnesyl transferase
CA2217477A1 (fr) Composes tricycliques utiles a l'inhibition de la transferase de proteine farnesyle
TW334432B (en) Tricyclic amide and urea compounds
CA2217499A1 (fr) Composes tricycliques utiles a l'inhibition de la fonction de la proteine-g et au traitement des maladies proliferatives
HK1017986A1 (en) Treating urinary incontinence using (s)-oxybutyninand (s)-desethyloxybutynin.
AU6049696A (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
MY117492A (en) New crystal modification of cdch, a process for its preparation and pharmaceutical formulations comprising this modification
DE69528591D1 (de) Herstellung des inhibitors fuer die komplexbildung des gewebefaktors
CA2213714A1 (fr) Guanidides alkenylcarboxyliques substitues par un phenyle , procede de preparation, utilisation comme medicament ou produit diagnostique et medicament contenant ces composes
AU7239996A (en) Inhibition of tumor necrosis factor alpha
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
EP0177366A3 (en) Enkephalinase b inhibitors, their preparation, and pharmaceutical compositions containing the same
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
CA2293714A1 (fr) Composes a base de cycloheptane benzpyrido servant d'inhibiteurs de farnesyl proteine transferase
CA2176796A1 (fr) Derives de substitution de benzyloxycarbonylguanidines; methode de preparation; utilisation comme medicament ou agent de diagnostic; medicament a base de ces derives
MY103871A (en) 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis.
IL124296A0 (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
AU6975591A (en) Pharmaceutical composition for treating or preventing retroviral infections
CA2189762A1 (fr) Utilisation de capteurs, d'inhibiteurs ou d'antagonistes d'oxyde nitrique dans le traitement de la migraine
EP0328420A3 (fr) Gangliosides contenant l'acide de-N-acétylsiatique et leur utilisation comme modificateurs de la physiologie des cellules

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed